Literature DB >> 17363830

Generalised anxiety disorder.

Christopher Gale1, Oliver Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17363830      PMCID： PMC1828319          DOI： 10.1136/bmj.39133.559282.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  DSM-IV and ICD-10 generalized anxiety disorder: discrepant diagnoses and associated disability.

Authors:  T Slade; G Andrews
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2001-01       Impact factor: 4.328

2.  Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.

Authors:  M H Pittler; E Ernst
Journal:  J Clin Psychopharmacol       Date:  2000-02       Impact factor: 3.153

3.  The Nottingham Study of Neurotic Disorder: predictors of 12-year outcome of dysthymic, panic and generalized anxiety disorder.

Authors:  Peter Tyrer; Helen Seivewright; Tony Johnson
Journal:  Psychol Med       Date:  2004-11       Impact factor: 7.723

4.  One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample.

Authors:  R M Carter; H U Wittchen; H Pfister; R C Kessler
Journal:  Depress Anxiety       Date:  2001       Impact factor: 6.505

5.  Longitudinal study of the influence of life events and personality status on diagnostic change in three neurotic disorders.

Authors:  N Seivewright; P Tyrer; B Ferguson; S Murphy; T Johnson
Journal:  Depress Anxiety       Date:  2000       Impact factor: 6.505

6.  A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder.

Authors:  Kristin Mitte; Peter Noack; Regina Steil; Martin Hautzinger
Journal:  J Clin Psychopharmacol       Date:  2005-04       Impact factor: 3.153

7.  A review and meta-analysis of the genetic epidemiology of anxiety disorders.

Authors:  J M Hettema; M C Neale; K S Kendler
Journal:  Am J Psychiatry       Date:  2001-10       Impact factor: 18.112

8.  A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies.

Authors:  D Westen; K Morrison
Journal:  J Consult Clin Psychol       Date:  2001-12

9.  Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies.

Authors:  R E Gammans; J C Stringfellow; A J Hvizdos; R J Seidehamel; J B Cohn; C S Wilcox; L F Fabre; J C Pecknold; W T Smith; K Rickels
Journal:  Neuropsychobiology       Date:  1992       Impact factor: 2.328

10.  12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project.

Authors:  J Alonso; M C Angermeyer; S Bernert; R Bruffaerts; T S Brugha; H Bryson; G de Girolamo; R Graaf; K Demyttenaere; I Gasquet; J M Haro; S J Katz; R C Kessler; V Kovess; J P Lépine; J Ormel; G Polidori; L J Russo; G Vilagut; J Almansa; S Arbabzadeh-Bouchez; J Autonell; M Bernal; M A Buist-Bouwman; M Codony; A Domingo-Salvany; M Ferrer; S S Joo; M Martínez-Alonso; H Matschinger; F Mazzi; Z Morgan; P Morosini; C Palacín; B Romera; N Taub; W A M Vollebergh
Journal:  Acta Psychiatr Scand Suppl       Date:  2004
View more
  7 in total

1.  Effects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior and contextual memory in rats.

Authors:  Max P Huang; Kushan Radadia; Brian W Macone; Sanford H Auerbach; Subimal Datta
Journal:  Behav Brain Res       Date:  2010-02-12       Impact factor: 3.332

2.  Threat reversal learning and avoidance habits in generalised anxiety disorder.

Authors:  Clark Roberts; Annemieke M Apergis-Schoute; Annette Bruhl; Magda Nowak; David S Baldwin; Barbara J Sahakian; Trevor W Robbins
Journal:  Transl Psychiatry       Date:  2022-05-31       Impact factor: 7.989

3.  The relationship between anxiety and sleep-wake behavior after stressor exposure in the rat.

Authors:  Robert Ross Maclean; Subimal Datta
Journal:  Brain Res       Date:  2007-06-27       Impact factor: 3.252

Review 4.  Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety.

Authors:  R E Nordquist; T Steckler; J G Wettstein; C Mackie; W Spooren
Journal:  Psychopharmacology (Berl)       Date:  2008-03-06       Impact factor: 4.530

5.  Comparative efficacy of face-to-face and internet-based cognitive behavior therapy for generalized anxiety disorder: A meta-analysis of randomized controlled trial.

Authors:  Wenle Zhang; Yun Du; Xiangyun Yang; Encong Wang; Jiexin Fang; Ziqi Liu; Shanqian Wu; Qinqin Liu; Yongdong Hu
Journal:  Front Psychiatry       Date:  2022-07-28       Impact factor: 5.435

6.  Evaluation of anxiolytic and sedative effect of essential oil and hydroalcoholic extract of Ocimum basilicum L. and chemical composition of its essential oil.

Authors:  Mohammed Rabbani; Seyed Ebrahim Sajjadi; Arefeh Vaezi
Journal:  Res Pharm Sci       Date:  2015 Nov-Dec

Review 7.  Social Isolation, Loneliness and Generalized Anxiety: Implications and Associations during the COVID-19 Quarantine.

Authors:  Linas Wilkialis; Nelson B Rodrigues; Danielle S Cha; Ashley Siegel; Amna Majeed; Leanna M W Lui; Jocelyn K Tamura; Barjot Gill; Kayla Teopiz; Roger S McIntyre
Journal:  Brain Sci       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.